GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor.
Eroglu EC, Kucukgoz Gulec U, Vardar MA, Paydas S. GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor. Eur J Mass Spectrom (Chichester). 2022 Feb; 28(1-2):12-24.